WS #13311
Preliminary merger talks between AstraZeneca and Bristol Myers Squibb could create a ~$400B pharma giant; BMY up ~6-8% premarket, AZN down ~5-6%.
AstraZeneca-Bristol Myers merger talks
Preliminary merger talks between AstraZeneca and Bristol Myers Squibb could create a ~$400B pharma giant; BMY up ~6-8% premarket, AZN down ~5-6%.